Your browser doesn't support javascript.
loading
Treatment-Free Remission After Second-Line Nilotinib Treatment in Patients With Chronic Myeloid Leukemia in Chronic Phase: Results From a Single-Group, Phase 2, Open-Label Study.
Mahon, François-Xavier; Boquimpani, Carla; Kim, Dong-Wook; Benyamini, Noam; Clementino, Nelma Cristina D; Shuvaev, Vasily; Ailawadhi, Sikander; Lipton, Jeffrey Howard; Turkina, Anna G; De Paz, Raquel; Moiraghi, Beatriz; Nicolini, Franck E; Dengler, Jolanta; Sacha, Tomasz; Takahashi, Naoto; Fellague-Chebra, Rafik; Acharya, Sandip; Wong, Stephane; Jin, Yu; Hughes, Timothy P.
Afiliación
  • Mahon FX; University of Bordeaux, Bordeaux, France (F.M.).
  • Boquimpani C; Hemocentro do Rio de Janeiro, HEMORIO, Rio de Janeiro, Brazil (C.B.).
  • Kim DW; The Catholic University of Korea, Seoul, South Korea (D.K.).
  • Benyamini N; Rambam Health Care Campus, Haifa, Israel (N.B.).
  • Clementino NCD; Hospital Das Clinicas da Universidade Federal de Minas Gerais, Belo Horizonte, Brazil (N.C.C.).
  • Shuvaev V; Russian Research Institute of Hematology and Transfusiology, Saint Petersburg, Russia (V.S.).
  • Ailawadhi S; Mayo Clinic, Jacksonville, Florida (S.A.).
  • Lipton JH; University of Toronto, Toronto, Ontario, Canada (J.H.L.).
  • Turkina AG; National Research Center for Hematology, Moscow, Russia (A.G.T.).
  • De Paz R; University Hospital La Paz, Madrid, Spain (R.D.).
  • Moiraghi B; Hospital General De Agudos J. M. Ramos Mejia, Buenos Aires, Argentina (B.M.).
  • Nicolini FE; Centre Hospitalier Lyon Sud, Pierre-Bénite, France (F.E.N.).
  • Dengler J; Onkologische Praxis Heilbronn, Heilbronn, Germany (J.D.).
  • Sacha T; Jagiellonian University Hospital, Kraków, Poland (T.S.).
  • Takahashi N; Akita University Hospital, Akita, Japan (N.T.).
  • Fellague-Chebra R; Novartis Pharma SAS, Rueil-Malmaison, France (R.F.).
  • Acharya S; Novartis Healthcare Pvt Ltd, Hyderabad, India (S.A.).
  • Wong S; Novartis Oncology Precision Medicine, Cambridge, Massachusetts (S.W.).
  • Jin Y; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey (Y.J.).
  • Hughes TP; University of Adelaide, Adelaide, South Australia, Australia (T.P.H.).
Ann Intern Med ; 168(7): 461-470, 2018 04 03.
Article en En | MEDLINE | ID: mdl-29459949
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pirimidinas / Leucemia Mielógena Crónica BCR-ABL Positiva / Inhibidores de Proteínas Quinasas Tipo de estudio: Clinical_trials Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pirimidinas / Leucemia Mielógena Crónica BCR-ABL Positiva / Inhibidores de Proteínas Quinasas Tipo de estudio: Clinical_trials Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Año: 2018 Tipo del documento: Article